Challenges and Opportunities for Pancreatic Cancer Immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Challenges and Opportunities for Pancreatic Cancer Immunotherapy

Published:2020-12 Issue:6 Volume:38 Page:788-802
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Bear Adham S.,Vonderheide Robert H.,O'Hara Mark H.

Funder

National Cancer Institute

Parker Institute for Cancer Immunotherapy

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference193 articles.

1. Intratumoral STING activation with T-cell checkpoint modulation generates systemic antitumor immunity;Ager;Cancer Immunol. Res.,2017

2. Signatures of mutational processes in human cancer;Alexandrov;Nature,2013

3. Genetic redirection of T cells for the treatment of pancreatic cancer;Ali;Front. Oncol.,2019

4. Obstacles posed by the tumor microenvironment to T cell activity: a case for synergistic therapies;Anderson;Cancer Cell,2017

5. Genomic analyses identify molecular subtypes of pancreatic cancer;Bailey;Nature,2016

Cited by 332 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapeutic strategies in hepatopancreatobiliary cancers;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025

2. Upregulation of HSD11B1 promotes cortisol production and inhibits NK cell activation in pancreatic adenocarcinoma;Molecular Immunology;2024-11

3. Overcoming therapy resistance in pancreatic cancer: New insights and future directions;Biochemical Pharmacology;2024-11

4. BCL6 overexpression in CD4+ T cells induces Tfh-like transdifferentiation and enhances antitumor efficiency of CAR-T therapy in pancreatic cancer;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

5. Neoadjuvant and Adjuvant Therapy in Resectable Pancreatic Adenocarcinoma;Surgical Clinics of North America;2024-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3